Earnings Release • May 5, 2021
Earnings Release
Open in ViewerOpens in native device viewer

May 5, 2021 at 7 a.m. CEST
| Underlying, (in € million) | Q1 2021 | Q1 2020 | % yoy | % organic |
|---|---|---|---|---|
| Net sales | 2,373 | 2,474 | -4.1% | +1.9% |
| EBITDA | 583 | 569 | +2.5% | +10.3% |
| EBITDA margin | 24.6% | 23.0% | +1.6pp | - |
| FCF to shareholders from continuing operations | 282 | 202 | +39.8% | - |
| FCF conversion ratio (LTM) | 54.8% | 40.4% | +14.4pp | - |
"First quarter results reflect the continued economic recovery visible across many of our markets. I am pleased to see that our disciplined structural actions taken last year to lower the company's cost base have enabled strong quality of earnings. We have also maintained our sharp focus on cash management, delivering eight consecutive quarters of positive free cash flow generation. Looking ahead, we are investing in our growth platforms, our front line, and in innovation that will support sustainable top line growth across the mid-term."
Full year underlying EBITDA is estimated between €2.0 and €2.2 billion, and Free Cash Flow is estimated around €650 million, up from the prior estimate between €600 and €650 million.
Register to the webcast scheduled at 15:00 CEST here - Link to financial report - Link to financial calendar
1 Barring additional deterioration related to a third wave of Covid-19 in the second half.
| Underlying, in € million | Q1 2021 | Q1 2020 | % yoy |
|---|---|---|---|
| Net sales | 2,373 | 2,474 | -4.1% |
| EBITDA | 583 | 569 | +2.5% |
| EBITDA margin | 24.6% | 23.0% | +1.6pp |
| EBIT | 382 | 371 | +2.9% |
| Net financial charges | -63 | -68 | +8.4% |
| Income tax expenses | -71 | -76 | +6.9% |
| Tax rate | 24% | 26% | -2.8pp |
| Profit / (loss) attributable to Solvay shareholders | 240 | 236 | +1.8% |
| Basic EPS | 2.33 | 2.28 | +1.9% |
| Basic EPS from continuing operations (in €) | 2.31 | 2.08 | +11.2% |
| Capex in continuing operations | 100 | 163 | -38.6% |
| FCF to Solvay shareholders from continuing operations | 282 | 202 | +39.8% |
| FCF to Solvay shareholders (total) | 282 | 197 | +43.0% |
| FCF conversion ratio (LTM) | 54.8% | 40.4% | +14.4pp |
| Net financial debt | 4,157 |
Net sales of €2,373 million in Q1 2021 were down 4.1% due mainly to the 5.9% negative impact from currency and scope, but up 1.9% organically. First quarter sales (+7% sequentially), marks the third consecutive sequential increase, reflecting improving market conditions across most businesses, especially in automotive, electronics, mining and construction industries. Volume growth in each of these markets combined with a supportive pricing environment drove the organic sales increase, which was partially offset by lower volumes in civil aerospace. Geographically, all regions progressed sequentially, with sales in China up by 30% versus the first quarter 2020.
Underlying EBITDA of €583 million was up 2.5% (+10.3% organically) in Q1 2021 as a result of higher sales and €80 million of additional structural cost savings. As a result, the EBITDA margin reached a record 24.6% in the quarter.
Free cash flow to shareholders from continuing operations reached €282 million, a 40% increase versus Q1 2020, reflecting continued discipline in working capital management, with working capital to sales ratio reaching 12% in Q1 2021. FCF was further supported by lower cash costs related to improvements in pension management.
Underlying net financial debt was roughly stable at €4.2 billion compared to December 2020, with strong free cash flow generation, the proceeds from divestments, the €52 million purchase of the EBRD shares in the Solvay holding of the Rusvinyl Joint Venture, and the €102 million additional voluntary pension contributions made in Belgium in January 2021. Credit ratings remain strong at BBB (S&P) and Baa2 (Moody's), and the outlook is now stable for both agencies following a recent improvement in outlook by Moody's.
Provisions are down by €208 million to €2.9 billion compared to December 2020, primarily related to €102 million voluntary pension contributions in Belgium and the impact of higher discount rates, and despite a €150 million non-cash restructuring provision related to the cost savings plan announced in February. Solvay continues to make progress on its pension funding roadmap, with cumulative funding of €768 million since Q4 2019, which has significantly reduced annual pension cash costs by more than €100 million.
| (in € million) | Q1 2020 | Scope | Forex | Volume | Price | Q1 2021 | Yoy % | Organic % |
|---|---|---|---|---|---|---|---|---|
| Materials | 789 | -8 | -36 | -51 | -5 | 689 | -12.7% | -7.5% |
| Chemicals | 800 | -3 | -52 | 29 | 16 | 791 | -1.2% | +6.1% |
| Solutions | 883 | -4 | -42 | 62 | -8 | 891 | +0.9% | +6.4% |
| Corporate | 1 | - | - | 1 | - | 3 | N/A | N/A |
| Solvay | 2,474 | -16 | -130 | 40 | 4 | 2,373 | -4.1% | +1.9% |
Sales in Q1 2021 were down 12.7% (7.5% organically) as headwinds in civil aero continue to weigh on the segment; a significant part of the decline was supported by continued recovery in specialty polymers.
Sales in Specialty Polymers increased by +6.3% (+10% organically) compared to the first quarter of 2020, and by +12% sequentially versus the fourth quarter 2020. This was driven by the continued strong demand in the automotive industry, partly related to the restocking effect. Automotive sales were up +19% organically versus Q1 2020, led by 80% growth in batteries for hybrid and electric vehicles. Other markets, including electronics and building were also solid, while healthcare was a bit softer than last year. Strong volume growth in Specialty Polymers was able to offset part of the headwinds related to civil aerospace.
Composite Materials sales were down 42.3% (36.6% organically) year on year, but improved by +8.6% sequentially versus the fourth quarter 2020. As expected, civil aerospace remains challenged yet improved sequentially compared to Q4 2020, while the defense and space sectors remain resilient.
Segment EBITDA decreased by 9.7% (4.7% organically) year on year, but was up +35% sequentially versus Q4, demonstrating the cost savings initiatives implemented in 2020, mainly attributed to the Composite Materials business following two plant closures. Pricing was sustained despite the various headwinds (raw material, supply chain and logistics issues). These initiatives supported a strong EBITDA margin of 29.9%.
First quarter 2021 sales in the segment were down 1.2% including forex and scope, but up +6.1% organically.
Soda Ash sales continued to improve sequentially, though were still 5.9% lower (-3.0% organically) than Q1 2020. The continuing recovery in building sustained good demand in flat glass, while demand for container glass used in the HORECA (hospitality, restaurant and catering) industry remained weak.
Peroxide sales were down by 11.1% (-4.7% organically), compared to Q1 2020, due to lower volumes in the pulp and paper markets in North America and Europe.
Silica sales were again strong +2.6% yoy (+7.9% organically), thanks to rising demand in the automotive segment, market share gain, and interest in our recently launched innovations.
Coatis had exceptional sales in this quarter, up +23.5% (+55% organically) with higher volumes and higher prices as a result of favorable market conditions.
Segment EBITDA was up +0.6% compared to Q1 2020 (+8.7% organically), and increased sequentially by 14.6% versus the fourth quarter 2020, as a result of favorable market conditions in Coatis combined with lower fixed costs in the business, as well as significant contributions from Rusvinyl, driven by strong PVC demand and higher prices. This resulted in a record underlying EBITDA margin of 30.4% in Q1 2021.
Sales in the first quarter of 2021 were up +0.9% (+6.4% organically) due mainly to higher volumes across most major markets.
First quarter sales in Novecare increased organically by 4.9% year on year, and increased organically by 13% excluding oil & gas; growth was driven by higher volumes in coatings, home & personal care, and agro markets. Oil & gas improved sequentially by +11% versus Q4, yet declined 31% year on year.
Special Chem sales increased +2.7% (organically by +8.6%) year on year thanks to the continued recovery in the automotive industry and sustained strong demand in the electronics market.
Technology Solutions sales increased by +9.4% (+14.5% organically) compared to Q1 2020 thanks to Copper mine site re-openings driving higher production levels and greater demand for our extractant solutions. Sequential sales versus Q4 improved by a similar magnitude.
Aroma Performance sales increased sequentially by +11.6% in Q1 versus Q4, due to strong volumes across product lines, but were down organically by 1.6% compared to a very strong Q1 2020. The business is investing to increase capacity in natural vanilla to capture the opportunity in this fast growing market.
First quarter EBITDA in the segment was up +12.4% (+21.1% organically) year and year, and up 26% sequentially, reflecting the continued recovery across most markets. EBITDA margin in the segment was up +2pp to 19.4% in Q1 2021, further reflecting our cost reduction improvements across all businesses.
| Segment review | Underlying | ||||
|---|---|---|---|---|---|
| (in € million) | Q1 2021 | Q1 2020 | % yoy | % organic | |
| Net sales | 2,373 | 2,474 | -4.1% | +1.9% | |
| Materials | 689 | 789 | -12.7% | -7.5% | |
| Specialty Polymers | 511 | 481 | +6.3% | +10.0% | |
| Composite Materials | 178 | 308 | -42.3% | -36.6% | |
| Chemicals | 791 | 800 | -1.2% | +6.1% | |
| Soda Ash & Derivatives | 367 | 390 | -5.9% | -3.0% | |
| Peroxides | 152 | 172 | -11.1% | -4.7% | |
| Coatis | 157 | 127 | +23.5% | +55.1% | |
| Silica | 114 | 111 | +2.6% | +7.9% | |
| Solutions | 891 | 883 | +0.9% | +6.4% | |
| Novecare | 416 | 421 | -1.3% | +4.9% | |
| Special Chem | 211 | 206 | +2.7% | +8.6% | |
| Technology Solutions | 154 | 140 | +9.4% | +14.5% | |
| Aroma Performance | 110 | 116 | -5.0% | -1.6% | |
| Corporate & Business Services | 3 | 1 | +81.4% | +94.1% | |
| EBITDA | 583 | 569 | +2.5% | +10.3% | |
| Materials | 206 | 228 | -9.7% | -4.7% | |
| Chemicals | 240 | 239 | +0.6% | +8.7% | |
| Solutions | 173 | 154 | +12.4% | +21.1% | |
| Corporate & Business Services | -36 | -52 | +30.3% | - | |
| EBITDA margin | 24.6% | 23.0% | +1.6pp | - | |
| Materials | 29.9% | 28.9% | +1.0pp | - | |
| Chemicals | 30.4% | 29.8% | +0.5pp | - | |
| Solutions | 19.4% | 17.4% | +2.0pp | - |
| IFRS | Underlying | ||||||
|---|---|---|---|---|---|---|---|
| (in € million) | Q1 2021 | Q1 2020 | % yoy | Q1 2021 | Q1 2020 | % yoy | |
| Net sales | 2,373 | 2,474 | -4.1% | 2,373 | 2,474 | -4.1% | |
| EBITDA | 414 | 485 | -14.7% | 583 | 569 | +2.5% | |
| EBITDA margin | 24.6% | 23.0% | +1.6pp | ||||
| EBIT | 169 | 233 | -27.5% | 382 | 371 | +2.9% | |
| Net financial charges | -30 | -27 | -11.8% | -63 | -68 | +8.4% | |
| Income tax expenses | -25 | -47 | +46.2% | -70 | -76 | +7.7% | |
| Tax rate | 24% | 26% | -2.7pp | ||||
| Profit / (loss) attributable to Solvay shareholders | 104 | 249 | -58.3% | 240 | 236 | +1.8% | |
| Basic EPS (in €) | 1.01 | 2.41 | -58.3% | 2.33 | 2.28 | +1.9% | |
| Basic EPS, from continuing operations (in €) | 1.01 | 1.43 | -29.5% | 2.31 | 2.08 | +11.2% | |
| Capex in continuing operations | 100 | 163 | -38.6% | ||||
| FCF to Solvay shareholders, continuing operations | 282 | 202 | +39.8% | ||||
| FCF to Solvay shareholders | 282 | 197 | +43.0% | ||||
| FCF conversion ratio (LTM) | 54.8% | 40.4% | +14.4pp | ||||
| Net financial debt | 4,157 |





EPS is earnings per share.
Extra-financial indicators: Indicators used to measure the sustainability performance of the company in complement to financial indicators. Solvay has selected 10 indicators that are included in the ONE Planet initiative. For more information, we refer to the last available annual report available on www.solvay.com.
Free cash flow to Solvay shareholders is the free cash flow after payment of net interests, coupons of perpetual hybrid bonds and dividends to non-controlling interests. This represents the cash flow available to Solvay shareholders, to pay their dividend and/or to reduce the net financial debt.
Free cash flow conversion ratio is calculated as the ratio between the free cash flow to Solvay shareholders of the last rolling 12 months (before netting of dividends paid to non-controlling interest) and the underlying EBITDA of the last rolling 12 months.
Organic growth excludes forex (foreign exchange conversion) and scope effects related to small M&A not leading to restatements.
Underlying figures adjust IFRS figures for the non-cash Purchase Price Allocation (PPA) accounting impacts related to acquisitions, for the coupons of perpetual hybrid bonds classified as equity under IFRS but treated as debt in the underlying statements, and for other elements to generate a measure that avoids distortion and facilitates the appreciation of performance and comparability of results over time.
Underlying net financial charges include the coupons on perpetual hybrid bonds (accounted as dividends under IFRS, and thereby excluded from the income statement), as well as the financial charges and realized foreign exchange losses from the RusVinyl joint venture (part of earnings from associates under IFRS, and thereby included in the IFRS EBITDA).
Underlying net financial debt includes the perpetual hybrid bonds, accounted for as equity under IFRS.
Jodi Allen +1 609 860 4608
Geoffroy d'Oultremont +32 2 264 29 97
Bisser Alexandrov +32 2 264 36 87
Nathalie Van Ypersele +32 478 20 10 62 [email protected]
Brian Carroll +32 471 70 54 72 [email protected]
Peter Boelaert +32 479 30 91 59 [email protected]
This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.
Solvay is a science company whose technologies bring benefits to many aspects of daily life. With more than 23,000 employees in 64 countries, Solvay bonds people, ideas and elements to reinvent progress. The Group seeks to create sustainable shared value for all, notably through its Solvay One Planet plan crafted around three pillars: protecting the climate, preserving resources and fostering better life. The Group's innovative solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices, health care applications, water and air purification systems. Founded in 1863, Solvay today ranks among the world's top three companies for the vast majority of its activities and delivered net sales of €9.0 billion in 2020. Solvay is listed on Euronext Brussels (SOLB) and Paris and in the United States, where its shares (SOLVY) are traded through a Level I ADR program. Learn more at www.solvay.com.
Results documentation Annual report G.R.O.W. Strategy Why invest in Solvay? Share information Credit information ESG information Webcasts, podcasts and presentations

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.